T1 Gene 1510 1515  mTOR
T3 Condition 789 795 cancer
T5 Condition 878 884 cancer
T6 Condition 758 764 cancer
T7 Biomarker 945 955 quetiapine
T8 Gene 1701 1727 MT2 melatonergic receptors
T9 Condition 420 424 bone
T10 Protein 188 192 ABC7
T11 Protein 1015 1019 drug
T12 Protein 1150 1154 drug
T14 Gene 1029 1037 TGF-beta
T15 Protein 1937 1941 ABC7
T16 Protein 1431 1436 eIF4E
T17 Condition 1903 1916 breast cancer
T18 Condition 403 416 breast cancer
T19 Biomarker 1294 1305 agomelatine
T20 Protein 1415 1419 drug
T22 Protein 1563 1568 eIF4E
T23 Biomarker 330 355 epithelial-to-mesenchymal
T25 Biomarker 525 541 already-marketed
T26 Protein 1322 1336 antidepressant
T27 Condition 1766 1772 cancer
T28 Condition 7 13 cancer
T29 Gene 1501 1509 TGF-beta
T30 Condition 291 297 cancer
T31 Protein 1001 1014 anti-fibrosis
T32 Protein 485 489 ABC7
T33 Biomarker 1126 1136 first-line
T34 Condition 871 884 breast cancer
T35 Protein 810 814 ABC7
T36 Protein 1168 1172 AMPK
T37 Condition 1892 1916 metastatic breast cancer
T38 Protein 905 909 ABC7
T40 Condition 410 416 cancer
T41 Condition 122 126 bone
T42 Protein 1350 1382 M1 and M2 melatonergic receptors
T43 Protein 299 303 ABC7
T44 Intervention 1113 1122 metformin
T47 Condition 284 297 breast cancer
T48 Biomarker 1052 1061 rifabutin
T49 Condition 1619 1632 breast cancer
T50 Condition 1759 1772 breast cancer
T52 Condition 624 630 cancer
T53 Protein 562 566 drug
T54 Biomarker 1391 1400 ribavirin
T55 Condition 1242 1254 beta-blocker
T56 Condition 131 144 breast cancer
T57 Protein 939 943 drug
T58 Protein 1693 1696 MT1
T59 Condition 28 32 bone
T60 Condition 215 228 Breast Cancer
T62 Condition 138 144 cancer
T63 Condition 545 551 cancer
T64 Biomarker 1227 1238 propranolol
T65 Biomarker 985 996 pirfenidone
